Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda

The malaria vaccine BK-SE36 is a recombinant protein (SE36) based on the Honduras 1 serine repeat antigen-5 of Plasmodium falciparum, adsorbed to aluminium hydroxide gel. The phase Ib trial in Uganda demonstrated the safety and immunogenicity of BK-SE36. Ancillary analysis in the follow-up study of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Yagi, Masanori, Palacpac, Nirianne M. Q., Ito, Kazuya, Oishi, Yuko, Itagaki, Sawako, Balikagala, Betty, Ntege, Edward H., Yeka, Adoke, Kanoi, Bernard N., Katuro, Osbert, Shirai, Hiroki, Fukushima, Wakaba, Hirota, Yoshio, Egwang, Thomas G., Horii, Toshihiro
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5050508/
https://ncbi.nlm.nih.gov/pubmed/27703240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep34363
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados